TG Therapeutics, Inc. ( TGTX) - Stock Earnings
TGTX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 2, 2026, midnight | — / — | — | — / — | — |
TGTX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 23.0 million USD | 192.6 million USD |
| 2026Q1 | 19.8 million USD | 204.9 million USD |
| 2026Q2 | 7.8 million USD | 240.3 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
TGTX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 12.7 million USD | 233.7 million USD |
| 2024 | 23.4 million USD | 329.0 million USD |
| 2025 | 447.2 million USD | 616.3 million USD |
| 2026 Est. | — | — |
TGTX
Price: $54.47
Earnings Per Share: 2.74 USD
P/E Ratio: 18.16
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 2.7 million
Ebitda: -31.6 millionMarket Capitalization: 8.3 billion